| EQA 2027 - Rivaroxaban (RIVA) |
|---|
|
Expert Biologists - Program Coordinators:
Béatrice GUILLEMIN EQA performed since 2017
Number of analytical sites registered in 2026: 134 |
| Program organised by ProBioQual and placed under the aegis of the FAEEQ |
|
1 – Program overview
This External Quality Assessment program evaluates the accuracy of Rivaroxaban assays. The main commercial assay methods are represented.
Statistical reports are sent with supporting comments from the expert clinical biologists who coordinate the program.
2 – Assessment frequency
Number of surveys per year: 4
Number of control samples per survey: 1 or 2
Number of samples per year: 6
3 – List of analytes assessed
4 – Description of the control samples
Lyophilised human control plasma (citrate) (samples to be resuspended in 1 mL of distilled water).
| | Legal notices and privacy policy | General Terms of Sale | | Last updated: 17 September 2026 | Copyright © 2011-2026 ProBioQual All rights reserved. |